Search - tctmd.com

Displaying 521 - 540 of 808

Sort: Relevancy | Date

Presentation TCT 2013

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Presenter: Jun-Won Lee, Sung Gyun Ahn, Ji-Hyun Lee, Seung-Hwan Lee, Junghan Yoon, Young-Jin Youn

January 31, 2013

Presentation TCT 2013

NOYA I: A Prospective Randomized Trial of the Biodegradable Polymer NOYA Sirolimus-Eluting Stent Compared with the Durable Polymer FIREBIRD 2 Sirolimus-Eluting Stent in Patients...

Presenter: Bo Xu, Kefei Dou, Yuejin Yang, Shuzheng Lu, Lefeng Wang, Haichang Wang, Zhanquan Li, Lei Wang, YunDai Chen, Yong Huo, Ajay Kirtane, Run-Lin Gao

January 31, 2013

Presentation TCT 2013

Neointimal growth patterns after between biodegradable polymer biolimus-eluting or permanent polymer everolimus-eluting stent implantation assessed with newly developed...

Presenter: Tomohisa Tada, Adnan Kastrati, Robert Byrne, Tibor Schuster, Rezarta Cuni, Lamin King, Salvatore Cassese, Michael Joner, Steffen Massberg, Albert Sch?mig, Julinda Mehilli

January 31, 2013

Presentation TCT 2013

Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

Presenter: Stefan Verheye, Mark Webster, James Stewart, Alexandre Abizaid, RICARDO COSTA, Jose Costa Jr, John Yan, vinayak bhat, lynn morrison, Sara Toyloy, John Ormiston

January 31, 2013

Presentation TCT 2013

Multi Center, Prospective, Randomized, Single Blind, Consecutive Enrollment Evaluation Of Elixir DESyneTM Novolimus-Eluting Coronary Stent System With Durable Polymer To Endeavo...

Presenter: Stefan Verheye, Christophe Dubois, Karl-Eugen Hauptmann, John Ormiston, James Stewart, Joachim Schofer, Karl Stangl, Bernhard Witzenbichler, Emanuele Barbato, Peter Fitzgerald, Hiromasa Otake, Patrick Serruys

January 31, 2013

Presentation TCT 2013

Luminal Fibrin as a Key Component in Mechanism of Action in Drug Coated Balloon Technologies

Presenter: Armando Tellez, Taylor Palmieri, Maxwell Afari, William Rate, Samantha Stone, Piotr Buszman, Greg Kaluza, Juan Granada

January 31, 2013

Presentation TCT 2013

Longitudinal Stent Deformation: Insights On Mechanisms, Treatments and Outcomes From The Food And Drug Administration Manufacturer And User Facility Device Experience Database

Presenter: Paul Williams, Mamas Mamas

January 31, 2013

Presentation TCT 2013

Late Catch-up Restenosis of Drug Eluting Stents: Evidence from Comparison with Bare Metal Stents in Japanese CAD Patients

Presenter: Yuki Horita, Masatoshi Ikeda, Isao Inoki, Masanobu Namura, Kenji Sakata, Hedenobu Terai

January 31, 2013

Presentation TCT 2013

Intimal Hyperplasia and Vascular Remodeling after Everolimus-eluting and Sirolimus-eluting Stent Implantation in Diabetic Patients. The Randomized Diabetes and Drug-Eluting Sten...

Presenter: Lisbeth Antonsen, Lisette Okkels Jensen, Michael Maeng, Per Thayssen, Evald H?j Christiansen, Knud N?rregaard Hansen, Anne Kaltoft, Henrik Steen Hansen, Leif Thuesen, Jens Flensted Lassen

January 31, 2013

Presentation TCT 2013

Impact of Varying Injury Severity and Multiple Treatments on Arterial Histopathology Early After Paclitaxel Coated Balloon Treatment of the Iliofemoral Arteries of Domestic Swine

Presenter: Maxwell Afari, Armando Tellez, Seung-Jin Oh, Krzysztof Milewski, Piotr Buszman, Renu Virmani, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2013

Impact of Moderate and Severe Coronary Calcification on 1-Year Outcomes after PCI with DES: A Pooled Analysis of 11,651 Patients from 14 Randomized Trials

Presenter: Philippe Genereux, Ajay Kirtane, Sorin Brener, Akiko Maehara, Tullio Palmerini, Martin Fahy, Roxana Mehran, Gregg Stone

January 31, 2013

Presentation TCT 2013

Gender impact on patients treated with drug-eluting stents – 3 year follow-up data.

Presenter: Fazilatum Nesa Malik, William Wijns, Dezs? APR?, G?rard Finet, JACQUES MONSEGU, Damras Tresukosol, David Hildick-Smith, Ciro Indolfi, Amerigo Stabile, Gian Battista Danzi

January 31, 2013

Presentation TCT 2013

Final Three Year Results Following Resolute Zotarolimus-eluting Stent Implantation in the RESOLUTE International Trial

Presenter: Franz-Josef Neumann, Petr Widimsky, Jorge Belardi

January 31, 2013

Presentation TCT 2013

Familial Hypercholesterolemic Swine In-Stent Restenosis Model, But Not Contemporaneous Injury+Treatment Model, Predicts Efficacy of Drug Coated Balloon in Peripheral Arteries

Presenter: Maxwell Afari, Armando Tellez, Yanping Cheng, Seung-Jin Oh, Piotr Buszman, Krzysztof Milewski, Jong Shiuan Yeh, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2013

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Presenter: Sachin Goel, Wael El-Mallah, Mobolaji Ige, Supriya Gupta, E Murat Tuzcu, Stephen Ellis, Samir Kapadia

January 31, 2013

Presentation TCT 2013

Efficacy and Safety of Drug-Eluting Balloon Compared to Drug-Eluting Stent for The Treatment of In-Stent Restenosis (ISR)

Presenter: Myung-Hyun Kim, Byeong-Keuk Kim

January 31, 2013

Presentation TCT 2013

Drug-eluting stent with biodegradable polymer in patients with STEMI – short and long term outcomes: data from e-NOBORI and NOBORI 2 trials

Presenter: Andres I?iguez, Farzin FATH-ORDOUBADHI, Isabel Calvo Cebollero, Albrecht Els?sser, Iskandar Atmowihardjo, Jorge Gaspar, Maciej Lesiak, Kai OPPENL?NDER, Nguyen Quang Ngoc, Ariel Roguin, Nicos Spyrou

January 31, 2013

Presentation TCT 2013

Drug-Coated Balloon for Peripheral Arteries: Results from preclinical experiments using the Freeway DCB

Presenter: Rembert Pogge von Strandmann, Mariann Gy?ngy?si, Stefanie Stahnke

January 31, 2013

Presentation TCT 2013

Drug Eluting Stent Fracture: Guiding the Study of Today and Tomorrow’s Stent Designs with Yesterday’s Clinical Experiences

Presenter: chad abunassar, Laura Kalvass, Santosh Prabhu

January 31, 2013

Presentation TCT 2013

Cost-effectiveness of paclitaxel-coated balloon angioplasty for treatment of coronary restenosis in bare-metal stents

Presenter: Klaus Bonaventura, Alexander Leber, Christian Sohns, Mattias Roser, Leif-Hendrik Boldt, Wilhelm Haverkamp, Marc Dorenkamp

January 31, 2013

Advertisement

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

NOYA I: A Prospective Randomized Trial of the Biodegradable Polymer NOYA Sirolimus-Eluting Stent Compared with the Durable Polymer FIREBIRD 2 Sirolimus-Eluting Stent in Patients...

Neointimal growth patterns after between biodegradable polymer biolimus-eluting or permanent polymer everolimus-eluting stent implantation assessed with newly developed...

Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

Multi Center, Prospective, Randomized, Single Blind, Consecutive Enrollment Evaluation Of Elixir DESyneTM Novolimus-Eluting Coronary Stent System With Durable Polymer To Endeavo...

Luminal Fibrin as a Key Component in Mechanism of Action in Drug Coated Balloon Technologies

Longitudinal Stent Deformation: Insights On Mechanisms, Treatments and Outcomes From The Food And Drug Administration Manufacturer And User Facility Device Experience Database

Late Catch-up Restenosis of Drug Eluting Stents: Evidence from Comparison with Bare Metal Stents in Japanese CAD Patients

Intimal Hyperplasia and Vascular Remodeling after Everolimus-eluting and Sirolimus-eluting Stent Implantation in Diabetic Patients. The Randomized Diabetes and Drug-Eluting Sten...

Impact of Varying Injury Severity and Multiple Treatments on Arterial Histopathology Early After Paclitaxel Coated Balloon Treatment of the Iliofemoral Arteries of Domestic Swine

Impact of Moderate and Severe Coronary Calcification on 1-Year Outcomes after PCI with DES: A Pooled Analysis of 11,651 Patients from 14 Randomized Trials

Gender impact on patients treated with drug-eluting stents – 3 year follow-up data.

Final Three Year Results Following Resolute Zotarolimus-eluting Stent Implantation in the RESOLUTE International Trial

Familial Hypercholesterolemic Swine In-Stent Restenosis Model, But Not Contemporaneous Injury+Treatment Model, Predicts Efficacy of Drug Coated Balloon in Peripheral Arteries

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Efficacy and Safety of Drug-Eluting Balloon Compared to Drug-Eluting Stent for The Treatment of In-Stent Restenosis (ISR)

Drug-eluting stent with biodegradable polymer in patients with STEMI – short and long term outcomes: data from e-NOBORI and NOBORI 2 trials

Drug-Coated Balloon for Peripheral Arteries: Results from preclinical experiments using the Freeway DCB

Drug Eluting Stent Fracture: Guiding the Study of Today and Tomorrow’s Stent Designs with Yesterday’s Clinical Experiences

Cost-effectiveness of paclitaxel-coated balloon angioplasty for treatment of coronary restenosis in bare-metal stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content